2012 | Aarkstore.com || Liver Cancer – Pipeline Review, H2 2012 by aarks222


									Aarkstore.com announces, The Latest market research report is available in
its vast collection:

Liver Cancer – Pipeline Review, H2 2012

You can also request for sample page of above mention reports on


Global Markets Direct’s, Liver Cancer - Pipeline Review, Global Markets Direct’s,
Liver Cancer - Pipeline Review, H2 2012, provides an overview of the indication’s
therapeutic pipeline. This report provides information on the therapeutic
development for Liver Cancer, complete with latest updates, and special features on
late-stage and discontinued projects. It also reviews key players involved in the
therapeutic development for Liver Cancer. Liver Cancer - Pipeline Review, Half Year
is built using data and information sourced from Global Markets Direct’s proprietary
databases, Company/University websites, SEC filings, investor presentations and
featured press releases from company/university sites and industry-specific third
party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.


- A snapshot of the global therapeutic scenario for Liver Cancer.
- A review of the Liver Cancer products under development by companies and
universities/research institutes based on information derived from company and
industry-specific sources.
- Coverage of products based on various stages of development ranging from
discovery till registration stages.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under
development for Liver Cancer.
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.

Table of contents:

List of Tables 6
List of Figures 8
Introduction 9
Global Markets Direct Report Coverage 9
Liver Cancer Overview 10
Therapeutics Development 11
An Overview of Pipeline Products for Liver Cancer 11
Liver Cancer Therapeutics under Development by Companies 13
Liver Cancer Therapeutics under Investigation by Universities/Institutes 17
Late Stage Products 22
Comparative Analysis 22
Mid Clinical Stage Products 23
Comparative Analysis 23
Early Clinical Stage Products 24
Comparative Analysis 24
Discovery and Pre-Clinical Stage Products 25
Comparative Analysis 25
Liver Cancer Therapeutics – Products under Development by Companies 26
Liver Cancer Therapeutics – Products under Investigation by Universities/Institutes
Companies Involved in Liver Cancer Therapeutics Development 34
Bristol-Myers Squibb Company 34
F. Hoffmann-La Roche Ltd. 35
Eli Lilly and Company 36
Tekmira Pharmaceuticals Corp. 37
Bavarian Nordic A/S 38
Kowa Company, Ltd. 39

List of Figures

List of Tables are also include.

For more related Reports Plz follow The link:

Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2

 Liver Cancer – Pipeline Review, H2 2012

 Non-Small Cell Lung Cancer – Pipeline Review, H2 2012

 Asthma – Pipeline Review, H2 2012

 Multiple Sclerosis – Pipeline Review, H2 2012

 Gastrointestinal Tract Cancer – Pipeline Review, H2 2012

 Diabetes – Pipeline Review, H2 2012

 Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2012

 Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review,
H2 2012

 Graft Versus Host Disease (GVHD) – Pipeline Review, H2 2012
 Malaria – Pipeline Review, H2 2012

 Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review,
H2 2012

 Dermatitis – Pipeline Review, H2 2012

Search More Reports Related to This Category :

Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and

For More details Plz do contact :

Aarkstore Enterprise



Email: enquiry@aarkstore.com

To top